Pharkem Molecules Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 5820.13%
- Profit Growth 7.42%
- Ebitda 27.01%
- Net Worth -108.74%
- Total Assets 49.27%
About Pharkem Molecules
Pharkem Molecules Private Limited (PMPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 22 September 2020 (Four years and four months 19 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anand Handa, Jignasha Gohel, Bhavesh Shukla, and One other member serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100GJ2020PTC116729
-
Company No.
116729
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Sep 2020
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Pharkem Molecules Private Limited offer?
Pharkem Molecules Private Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Fatty Esters.
Who are the key members and board of directors at Pharkem Molecules?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anand Handa
|
Director | 22-Sep-2020 | Current |
|
Jignasha Gohel
|
Director | 22-Sep-2020 | Current |
|
Bhavesh Shukla
|
Director | 22-Sep-2020 | Current |
|
Jhankhana Gajjar
|
Director | 29-Oct-2020 | Current |
Financial Performance of Pharkem Molecules.
Pharkem Molecules Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 5820.13% increase. The company also saw a slight improvement in profitability, with a 7.42% increase in profit. The company's net worth observed a substantial decline by a decrease of 108.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharkem Molecules?
Unlock access to Pharkem Molecules's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharkem Molecules?
Pharkem Molecules has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharkem Molecules, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharkem Molecules's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.